Clinical-stage biotech company Pfenex gets FDA's approval for PF708. Pfenex is conducting a comparative study between PF708 and Eli Lilly's Forteo and will submit the final study report to FDA later this month.
anonymous
Thread
biotech
drug
eli lilly
ema
fda
forteo
fracture
osteoporosis
pf708
pfenex
How is forteo doing? Hard sell? What's the status of the Effient reps? Any word as to what we will get to replace Effient? Thinking about switching divisions.